1. Home
  2. MBINM vs VCEL Comparison

MBINM vs VCEL Comparison

Compare MBINM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINM
  • VCEL
  • Stock Information
  • Founded
  • MBINM N/A
  • VCEL 1989
  • Country
  • MBINM United States
  • VCEL United States
  • Employees
  • MBINM 663
  • VCEL N/A
  • Industry
  • MBINM Major Banks
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MBINM Finance
  • VCEL Health Care
  • Exchange
  • MBINM Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • MBINM N/A
  • VCEL 2.1B
  • IPO Year
  • MBINM N/A
  • VCEL 1997
  • Fundamental
  • Price
  • MBINM $25.05
  • VCEL $39.98
  • Analyst Decision
  • MBINM
  • VCEL Strong Buy
  • Analyst Count
  • MBINM 0
  • VCEL 8
  • Target Price
  • MBINM N/A
  • VCEL $62.00
  • AVG Volume (30 Days)
  • MBINM N/A
  • VCEL 476.9K
  • Earning Date
  • MBINM N/A
  • VCEL 07-31-2025
  • Dividend Yield
  • MBINM N/A
  • VCEL N/A
  • EPS Growth
  • MBINM N/A
  • VCEL 521.85
  • EPS
  • MBINM N/A
  • VCEL 0.05
  • Revenue
  • MBINM N/A
  • VCEL $238,541,000.00
  • Revenue This Year
  • MBINM N/A
  • VCEL $23.03
  • Revenue Next Year
  • MBINM N/A
  • VCEL $24.52
  • P/E Ratio
  • MBINM N/A
  • VCEL $675.02
  • Revenue Growth
  • MBINM N/A
  • VCEL 14.80
  • 52 Week Low
  • MBINM N/A
  • VCEL $37.39
  • 52 Week High
  • MBINM N/A
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • MBINM 48.98
  • VCEL 42.08
  • Support Level
  • MBINM $24.81
  • VCEL $39.39
  • Resistance Level
  • MBINM $25.18
  • VCEL $42.61
  • Average True Range (ATR)
  • MBINM 0.15
  • VCEL 1.61
  • MACD
  • MBINM 0.01
  • VCEL -0.20
  • Stochastic Oscillator
  • MBINM 60.53
  • VCEL 11.60

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: